World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
33714
World Ranking
9306
National Ranking
4801

Overview

Alan B. Cantor is affiliated with Harvard University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields including Molecular Biology, Hematology, Genetics, Cancer Research, and Cell Biology.

The scientist's work covers various topics in biomedical research with a focus on Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Platelet Disorders and Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Zebrafish Biomedical Research Applications, Breast Cancer Treatment Studies, and Blood disorders and treatments.

Alan B. Cantor has published several recent papers across different venues. Notable publications include:

  • A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study, 2020, Neuro-Oncology
  • The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy, 2021, Haematologica
  • Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits, 2020, Nature Genetics
  • Role of RUNX Family Transcription Factors in DNA Damage Response., 2020, PubMed
  • Infantile Myelofibrosis and Myeloproliferation with CDC42Dysfunction, 2020, Journal of Clinical Immunology

Frequent publication venues for Cantor's work include Blood, Experimental Hematology, Blood Advances, bioRxiv (Cold Spring Harbor Laboratory), and UNC Libraries.

The scientist has collaborated repeatedly with certain colleagues, including Nah-Young Shin, Michael W. Drazer, Lucy A. Godley, Anna Brown, and Claire C. Homan.

Best Publications

  • Lymphatic mapping and sentinel node biopsy in the patient with breast cancer

    John J. Albertini;Gary H. Lyman;Charles Cox;Tim Yeatman

  • Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A

    Vijay G. Sankaran;Tobias F. Menne;Jian Xu;Thomas E. Akie

  • Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

    Akira Nakagawara;Miwako Arima-Nakagawara;Nancy J. Scavarda;Christopher G. Azar

  • BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

    Tuya Pal;Jenny Permuth-Wey;A R N Judith Betts;Jeffrey P. Krischer

  • Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

    Michelle A. Blaskovich;Jiazhi Sun;Alan Cantor;James Turkson

  • Transcriptional regulation of erythropoiesis: an affair involving multiple partners.

    Alan B Cantor;Stuart H Orkin;Stuart H Orkin

  • A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs

    Jonghwan Kim;Andrew J. Woo;Jianlin Chu;Jonathan W. Snow

  • Constitutive Activation of Stat3 in Human Prostate Tumors and Cell Lines Direct Inhibition of Stat3 Signaling Induces Apoptosis of Prostate Cancer Cells

    Linda B Mora;Ralf Buettner;John Seigne;Jose Diaz

  • Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo

    Channing Yu;Alan B. Cantor;Haidi Yang;Carol Browne

  • The uncertainty principle and industry-sponsored research

    Benjamin Djulbegovic;Mensura Lacevic;Alan Cantor;Karen K Fields

  • Osteopontin identified as lead marker of colon cancer progression, using pooled Sample expression profiling

    Deepak Agrawal;Tingan Chen;Rosalyn Irby;John Quackenbush

  • RRM1 Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer

    Gerold Bepler;Irina Kusmartseva;Swati Sharma;Ashish Gautam

  • Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

    Maria Friberg;Ronald Jennings;Marwan Alsarraj;Sophie Dessureault

  • Lysophospholipids are potential biomarkers of ovarian cancer.

    Rebecca Sutphen;Yan Xu;George D Wilbanks;James Fiorica

  • Molecular Staging for Survival Prediction of Colorectal Cancer Patients

    Steven Eschrich;Ivana Yang;Greg Bloom;Ka Yin Kwong

  • ERCC1 Expression Is a Predictor of Survival in Resected Patients With Non-small Cell Lung Cancer

    George R Simon;Swati Sharma;Alan Cantor;Prudence Smith

  • Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression

    Nills Diaz;Susan Minton;Charles Cox;Tammy Bowman

  • Insights into GATA-1 Mediated Gene Activation versus Repression via Genome-wide Chromatin Occupancy Analysis

    Ming Yu;Laura Riva;Huafeng Xie;Yocheved Schindler

  • The Efficacy and Safety of Pain Management Before and After Implementation of Hospital-Wide Pain Management Standards: Is Patient Safety Compromised by Treatment Based Solely on Numerical Pain Ratings?

    Hector Vila;Robert A. Smith;Michael J. Augustyniak;Peter A. Nagi

  • The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects

    Jane D. Carver;Valerie J. Benford;Beth Han;Alan B. Cantor

Frequent Co-Authors

Stuart H. Orkin
Stuart H. Orkin Harvard University
Charles E. Cox
Charles E. Cox University of South Florida
Barry H. Paw
Barry H. Paw Brigham and Women's Hospital
Douglas S. Reintgen
Douglas S. Reintgen University of South Florida
Eric B. Haura
Eric B. Haura University of South Florida
Daniel E. Bauer
Daniel E. Bauer Harvard University
Leonard I. Zon
Leonard I. Zon Harvard University
Jane L. Messina
Jane L. Messina University of South Florida
Scott J. Antonia
Scott J. Antonia Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re planning to study Medicine in the USA, there are several online degree options and career pathways to consider—especially in the field of nursing. For practicing nurses aiming for advanced practice roles, some of the cheapest dnp programs make achieving a terminal nursing degree more affordable and accessible.

Students with an RN can look into affordable rn to bsn programs to advance their credentials without leaving their current jobs. These flexible online programs often feature lower tuition and convenient schedules, making them ideal for working professionals.

If you have a non-nursing bachelor’s degree but dream of entering the nursing profession, there are direct entry msn programs for non-nursing majors that streamline your path toward a master’s degree in nursing.

Those seeking the quickest and most accessible way into nursing should also review the online bsn programs for non nurses designed to be less competitive and more straightforward to gain admission.

Best Scientists Citing Alan B. Cantor

Trending Scientists

Recently Published Articles